pravastatin has been researched along with carboplatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CI; Chao, YC; Chen, HH; Chen, JJ; Cheng, CF; Chiu, TH; Juan, SH; Lian, WS; Lin, H; Lu, CY | 1 |
| Chen, HH; Chen, TW; Lin, H | 1 |
| Crosse, B; Cullen, M; Fife, KM; Hackshaw, A; Harden, S; Middleton, G; Muthukumar, D; Nash, S; Ngai, Y; Ottensmeier, CH; Schmid, P; Seckl, MJ; Taylor, P; Thompson, J | 1 |
1 trial(s) available for pravastatin and carboplatin
| Article | Year |
|---|---|
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pravastatin; Response Evaluation Criteria in Solid Tumors; Small Cell Lung Carcinoma; Survival Rate | 2017 |
2 other study(ies) available for pravastatin and carboplatin
| Article | Year |
|---|---|
Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carboplatin; Cardiomyopathies; Carrier Proteins; Caspases; Cells, Cultured; Enzyme Activation; Heart; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Leukopenia; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Oxidative Stress; Pravastatin; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species | 2008 |
Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Chromatin Immunoprecipitation; Drug Interactions; Electrophoretic Mobility Shift Assay; Heme Oxygenase (Decyclizing); Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Mice; Mice, Knockout; PPAR alpha; Pravastatin; Promoter Regions, Genetic | 2010 |